---
$id: https://graph.org.ai/products/commodity/51372106
$type: Product
source: UNSPSC
code: "51372106"
title: "Hydrocodone or dihydrocodeinone"
class: "51372100"
classTitle: "Controlled substance analgesic morphine derivatives"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hydrocodone or dihydrocodeinone

**UNSPSC Code**: 51372106
**Class**: [Controlled substance analgesic morphine derivatives](Controlled substance analgesic morphine derivatives.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid and antitussive agent with the molecular formula C18H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6YKS4Y3WQ7, chemically known as 4,5-epoxy-3-methoxy-17-methylmorphinan-6-one but generally known as hydrocodone, which bears US NIH Compound Identifier 5284569. European Medicines Agency schedules Hydrocodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08063MIG. The term HYDROCODONE is an International Non-Proprietary Name. World Health Organization schedules hydrocodone in its Anatomical Therapeutic Chemical (ATC) Classification. HYDROCODONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Hydrocodone or dihydrocodeinone bears US NLM identifiers UMLS ID C0020264 and NCI Concept Code C62033. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OC)CC3)CCC2=O.

